A comprehensive view of U.S. Food and Drug Administration (FDA). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Sustainability & Social Responsibility Market Intelligence Service.
Bimatoprost found to be the most effective and only FDA-approved ingredient for eyelash serums shown to increase eyelash length safely, according to a review in the Journal of Cosmetic Dermatology
Published:
April 22, 2024
by CosmeticsDesign.com (US)
|
FDA approves subcutaneous administration of Takeda’s ENTYVIO (vedolizumab) for maintenance therapy in moderately to severely active Crohn’s Disease
Published:
April 19, 2024
by Business Wire
|
Vanda Pharmaceuticals thwarts a hostile takeover bid from Future Pak by implementing a shareholder rights plan or 'poison pill' strategy; the bid follows FDA approval for the expansion of its antipsychotic drug Fanapt
Published:
April 19, 2024
by FiercePharma
|
High demand for injectable weight-loss drugs has led to supply issues, with most varieties listed in short supply by the FDA; Eli Lilly reports shortages of its Zepbound and Mounjaro could last until 2025
Published:
April 19, 2024
by CBS - 12 WJTV (Jackson, MS)
|
FDA approves Roche's oral Alecensa for ALK-positive early-stage lung cancer treatment following successful Phase 3 trial; trial results show Alecensa reduced the risk of disease recurrence or death by 76%
Published:
April 19, 2024
by F. Hoffmann-La Roche Ltd. (Roche)
|
Ask us about our Sustainability & Social Responsibility market view